Literature DB >> 12754360

The clinicopathological spectrum of Rosenthal fibre encephalopathy and Alexander's disease: a case report and review of the literature.

J Jacob1, N J Robertson, D A Hilton.   

Abstract

Alexander's disease is a leucodystrophy that usually presents in early childhood, but can infrequently arise in adults. It is characterised pathologically by megalencephaly, demyelination, and the presence of numerous Rosenthal fibres. Most cases have been shown to be due to mutations in the gene encoding glial fibrillary acidic protein. In rare instances, numerous Rosenthal fibres have been found at autopsy in patients who have suffered protracted debilitating systemic illnesses, some with associated brain stem signs, and in very rare instances in patients with no apparent neurological abnormality. The term "Rosenthal fibre encephalopathy" is used to distinguish these cases from those of Alexander's disease. We report the first case of Rosenthal fibre encephalopathy in a young man with AIDS, and review the literature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12754360      PMCID: PMC1738489          DOI: 10.1136/jnnp.74.6.807

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

Review 1.  The clinical spectrum of late-onset Alexander disease: a systematic literature review.

Authors:  Pietro Balbi; Silvana Salvini; Cira Fundarò; Giuseppe Frazzitta; Roberto Maestri; Dibo Mosah; Carla Uggetti; GianPietro Sechi
Journal:  J Neurol       Date:  2010-08-20       Impact factor: 4.849

2.  Insights into the domains required for dimerization and assembly of human alphaB crystallin.

Authors:  Joy G Ghosh; John I Clark
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

3.  Child Neurology: Pediatric seizures with hyaline astrocytic inclusions.

Authors:  Janice C Wong; Brent O'Neill; Cynthia E Hawkins; B K Kleinschmidt-DeMasters; Lili-Naz Hazrati
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

Review 4.  Young-onset dementia.

Authors:  Dulanji K Kuruppu; Brandy R Matthews
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

5.  Archetypal and new families with Alexander disease and novel mutations in GFAP.

Authors:  Albee Messing; Rong Li; Sakkubai Naidu; J Paul Taylor; Lital Silverman; Daniel Flint; Marjo S van der Knaap; Michael Brenner
Journal:  Arch Neurol       Date:  2011-10-10

6.  Infantile onset alexander disease with normal head circumference: a genetically proven case report.

Authors:  Manisha Goyal; Sumit Mehndiratta; Mohammed Faruq; Manish Kumar Dwivedi; Seema Kapoor
Journal:  J Clin Diagn Res       Date:  2014-11-20

7.  Identification of association fibers using ex vivo diffusion tractography in Alexander disease brains.

Authors:  Tadashi Shiohama; Natalie Stewart; Masahito Nangaku; Andre J W van der Kouwe; Emi Takahashi
Journal:  J Neuroimaging       Date:  2022-08-19       Impact factor: 2.324

Review 8.  Adult-onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literature.

Authors:  Michito Namekawa; Yoshihisa Takiyama; Junko Honda; Haruo Shimazaki; Kumi Sakoe; Imaharu Nakano
Journal:  BMC Neurol       Date:  2010-04-01       Impact factor: 2.474

Review 9.  Astrocytes: the missing link in neurologic disease?

Authors:  Chia-Ching John Lin; Benjamin Deneen
Journal:  Semin Pediatr Neurol       Date:  2013-10-16       Impact factor: 1.636

10.  GFAP mutations, age at onset, and clinical subtypes in Alexander disease.

Authors:  M Prust; J Wang; H Morizono; A Messing; M Brenner; E Gordon; T Hartka; A Sokohl; R Schiffmann; H Gordish-Dressman; R Albin; H Amartino; K Brockman; A Dinopoulos; M T Dotti; D Fain; R Fernandez; J Ferreira; J Fleming; D Gill; M Griebel; H Heilstedt; P Kaplan; D Lewis; M Nakagawa; R Pedersen; A Reddy; Y Sawaishi; M Schneider; E Sherr; Y Takiyama; K Wakabayashi; J R Gorospe; A Vanderver
Journal:  Neurology       Date:  2011-09-14       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.